This is a preview of subscription content, log in via an institution to check access.
Notes
dipeptidyl peptidase-4 inhibitors (CD26 antigen inhibitors)
Reference
FDA. FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain. Internet Document : 28 Aug 2015. Available from: URL: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM460038.pdf
Rights and permissions
About this article
Cite this article
DPP-4 inhibitors may cause severe joint pain. Reactions Weekly 1568, 2 (2015). https://doi.org/10.1007/s40278-015-5060-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-5060-2